{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:29:52Z","timestamp":1749634192448},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1994,2,1]]},"DOI":"10.1227\/00006123-199402000-00013","type":"journal-article","created":{"date-parts":[[2010,5,30]],"date-time":"2010-05-30T09:25:53Z","timestamp":1275211553000},"page":"297-308","source":"Crossref","is-referenced-by-count":10,"title":["The Efficacy and Distribution of Suramin in the Treatment of the 9L Gliosarcoma"],"prefix":"10.1227","volume":"34","author":[{"given":"Jeffrey J.","family":"Olson","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrel M.","family":"Polk","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Reisner","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"key\n\t\t\t\t20180504093750_R1-13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0304-3835(92)90194-Z","article-title":"Insulin-like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth","volume":"62","author":"Baghdiguian","year":"1992","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t20180504093750_R2-13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.2649981","article-title":"Chromosome 17 deletions and p53 mutations in colorectal carcinomas","volume":"244","author":"Baker","year":"1989","journal-title":"Science"},{"key":"key\n\t\t\t\t20180504093750_R3-13","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1073\/pnas.83.17.6440","article-title":"Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin","volume":"83","author":"Betsholtz","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180504093750_R4-13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0165-4608(87)90045-8","article-title":"Relationship between gene amplification and chromosomal deviations in malignant human gliomas","volume":"29","author":"Bigner","year":"1987","journal-title":"Cancer Genet Cytogenet"},{"key":"key\n\t\t\t\t20180504093750_R5-13","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1073\/pnas.89.7.3025","article-title":"Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells","volume":"89","author":"Bojanski","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180504093750_R6-13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/327293a0","article-title":"Prevalence of ras gene mutations in human colorectal cancers","volume":"327","author":"Bos","year":"1987","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180504093750_R7-13","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1172\/JCI115708","article-title":"Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells","volume":"89","author":"Cardinali","year":"1992","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180504093750_R8-13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jcp.1041320120","article-title":"Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells","volume":"132","author":"Coffey","year":"1987","journal-title":"J Cell Physiol"},{"key":"key\n\t\t\t\t20180504093750_R9-13","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1073\/pnas.77.6.3700","article-title":"Experimental animal model for mucopolysaccharidosis: Suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat","volume":"77","author":"Constantopoulos","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180504093750_R10-13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/clpt.1992.97","article-title":"Adaptive control with feedback strategies for suramin dosing","volume":"52","author":"Cooper","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20180504093750_R11-13","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0021-9258(19)35450-X","article-title":"Acidic and basic fibroblastic growth factors simulate tyrosine kinase activity in vivo","volume":"263","author":"Coughlin","year":"1988","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180504093750_R12-13","first-page":"578","article-title":"Effect of suramin on glioma line U706T","volume":"30","author":"Danesi","year":"1989","journal-title":"Proc Am Assoc Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R13-13","first-page":"1209","article-title":"Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses","volume":"226","author":"De Clerq","year":"1979","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t20180504093750_R14-13","first-page":"239","article-title":"Passage provoque de la suramine au travers de la barriere hemato-encephalique","volume":"67","author":"Dereymaeker","year":"1987","journal-title":"Ann Soc Belge Med Trop"},{"key":"key\n\t\t\t\t20180504093750_R15-13","first-page":"2164","article-title":"Genes for epidermal growth factor receptor, transforming growth factor-alpha, and epidermal growth factor and their expression in human gliomas in vivo","volume":"51","author":"Ekstrand","year":"1991","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R16-13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ijc.2910450330","article-title":"Suramin inhibits proliferation of rat gliomas cells and alters N-CAM cell surface expression","volume":"45","author":"Fantini","year":"1990","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180504093750_R17-13","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1016\/S0021-9258(18)81797-5","article-title":"Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4","volume":"264","author":"Fantini","year":"1989","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180504093750_R18-13","first-page":"1355","article-title":"Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro","volume":"7","author":"Fleming","year":"1992","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180504093750_R19-13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ijc.2910510317","article-title":"Pleiotropic actions of suramin on the proliferation of human breast cancer cells in vitro","volume":"51","author":"Foekens","year":"1992","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180504093750_R20-13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1126\/science.2432664","article-title":"Angiogeneic factors","volume":"235","author":"Folkman","year":"1987","journal-title":"Science"},{"key":"key\n\t\t\t\t20180504093750_R21-13","first-page":"393","article-title":"A heparin binding angiogenic protein\u2013basic fibroblastic growth factor\u2013is stored in the basement membrane","volume":"130","author":"Folkman","year":"1988","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20180504093750_R22-13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0005-2736(73)90119-3","article-title":"Suramin: A potent ATPase inhibitor which acts on the inside surface of the sodium pump","volume":"318","author":"Fortes","year":"1973","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180504093750_R23-13","first-page":"5073","article-title":"Inhibition of angiogenesis by suramin","volume":"52","author":"Gagliardi","year":"1992","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R24-13","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-5347(17)36776-9","article-title":"Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures","volume":"148","author":"Gansler","year":"1992","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20180504093750_R25-13","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1073\/pnas.81.23.7466","article-title":"Blockade of autocrine stimulation in simian sarcoma virus transformed cells reverses down-regulation of platelet-derived growth factor receptors","volume":"81","author":"Garrett","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180504093750_R26-13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1054-3589(08)60486-X","article-title":"Suramin: with special reference to onchocerciasis","volume":"15","author":"Hawking","year":"1978","journal-title":"Adv Pharmacol Chemother"},{"key":"key\n\t\t\t\t20180504093750_R27-13","first-page":"277","article-title":"Structure and metabolism of proteoglycans","volume-title":"Extracellular Matrix Biochemistry","author":"Heinegard","year":"1984"},{"key":"key\n\t\t\t\t20180504093750_R28-13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0014-5793(89)81639-4","article-title":"Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A","volume":"258","author":"Hensey","year":"1989","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20180504093750_R29-13","first-page":"273","article-title":"Circulating glycosaminoglycan anticoagulants associated with suramin treatment","volume":"71","author":"Horne","year":"1988","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180504093750_R30-13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/s-0038-1648466","article-title":"The effect of suramin on laboratory tests of coagulation","volume":"67","author":"Horne","year":"1992","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20180504093750_R31-13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-230X(08)60293-6","article-title":"Molecular genetic characterization of CNS tumor oncogenesis","volume":"58","author":"James","year":"1992","journal-title":"Adv Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R32-13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1080\/01483918508074087","article-title":"Quantitation of suramin by reverse-phase ion-pairing high performance liquid chromatography","volume":"8","author":"Klecker","year":"1985","journal-title":"J Liquid Chromatog"},{"key":"key\n\t\t\t\t20180504093750_R33-13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0960-0760(90)90471-V","article-title":"Growth factor-receptor pathway interfering treatment by somatostatin analogs and suramin: Preclinical and clinical studies","volume":"37","author":"Klijn","year":"1990","journal-title":"J Steroid Biochem Molec Biol"},{"key":"key\n\t\t\t\t20180504093750_R34-13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/oxfordjournals.annonc.a058264","article-title":"A pilot study of suramin in the treatment of progressive refractory follicular lymphomas","volume":"3","author":"LaRocca","year":"1992","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180504093750_R35-13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0094-0143(21)01399-9","article-title":"Use of suramin in prostatic carcinoma refractory to conventional hormonal manipulation","volume":"18","author":"LaRocca","year":"1991","journal-title":"Urol Clin North Am"},{"key":"key\n\t\t\t\t20180504093750_R36-13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0960-0760(90)90439-R","article-title":"Suramin, a novel antitumor compound","volume":"37","author":"LaRocca","year":"1990","journal-title":"J Steroid Biochem Molec Biol"},{"key":"key\n\t\t\t\t20180504093750_R37-13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1083\/jcb.118.5.1057","article-title":"Intracellular retention of membrane anchored v-sis protein abrogates autocrine signal production","volume":"118","author":"Lee","year":"1992","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20180504093750_R38-13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/bjc.1992.268","article-title":"Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblastic growth factor or suramin","volume":"66","author":"Leith","year":"1992","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180504093750_R39-13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-105-1-32","article-title":"Suramin antiviral therapy in the acquired immunodeficiency syndrome","volume":"105","author":"Levine","year":"1986","journal-title":"Ann Int Med"},{"key":"key\n\t\t\t\t20180504093750_R40-13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/313144a0","article-title":"Amplification enhanced expression and possible rearrangement of the EGF receptor gene in primary brain tumors of glial origin","volume":"313","author":"Liberman","year":"1985","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180504093750_R41-13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.2910510615","article-title":"The effect of schedule, protein binding and growth factors on the activity of suramin","volume":"51","author":"Lopez-Lopez","year":"1992","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180504093750_R42-13","first-page":"5424","article-title":"Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C","volume":"265","author":"Mahoney","year":"1990","journal-title":"Differential activation and inhibition of protein kinase C isozymes. J Biol Chem"},{"key":"key\n\t\t\t\t20180504093750_R43-13","first-page":"2711","article-title":"Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme","volume":"48","author":"Malden","year":"1988","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R44-13","first-page":"323","article-title":"Use of collagen gel culture to study heart development: Proteoglycan and glycoprotein interactions during the formation of endocardial cushion tissue","volume-title":"The Role of Extracellular Matrix in Development","author":"Markwald","year":"1984"},{"key":"key\n\t\t\t\t20180504093750_R45-13","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1126\/science.2595361","article-title":"Many gene alterations found in cancer","volume":"246","author":"Marx","year":"1989","journal-title":"Science"},{"key":"key\n\t\t\t\t20180504093750_R46-13","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0277-5379(91)90118-W","article-title":"Fatal toxic epidermal necrolysis during suramin therapy","volume":"27","author":"May","year":"1991","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20180504093750_R47-13","first-page":"1830","article-title":"Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop","volume":"52","author":"Minniti","year":"1992","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R48-13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.6091268","article-title":"Suramin protection of T cells in vitro against the infectivity and cytopathic effect of HTLV III","volume":"226","author":"Mitsuya","year":"1984","journal-title":"Science"},{"key":"key\n\t\t\t\t20180504093750_R49-13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0014-5793(88)80121-2","article-title":"Inhibition of vacuolar H+-ATPases by fucidic acid and suramin","volume":"234","author":"Moriyama","year":"1988","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20180504093750_R50-13","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1083\/jcb.109.5.2519","article-title":"Transformation of NIH 3T3 cells with basic fibroblastic growth factor of the hst\/K-flg oncogene causes downregulation of the fibroblast growth factor receptor: Reversal of morphological transformation and restoration of receptor number by suramin","volume":"109","author":"Moscatelli","year":"1989","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20180504093750_R51-13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.1992.10.6.881","article-title":"Suramin: A novel growth factor antagonist with activity in hormone-refractory metastatic-prostate cancer","volume":"10","author":"Myers","year":"1992","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180504093750_R52-13","first-page":"3910","article-title":"Expression of messenger RNA's for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines","volume":"48","author":"Nister","year":"1988","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R53-13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archderm.1992.01680110085011","article-title":"Suramin-induced skin reactions","volume":"128","author":"O'Donnell","year":"1992","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t20180504093750_R54-13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1432-1033.1988.tb13893.x","article-title":"Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin","volume":"172","author":"Ono","year":"1988","journal-title":"Eur J Biochem"},{"key":"key\n\t\t\t\t20180504093750_R55-13","first-page":"85","article-title":"Guide for the Care and Use of Laboratory Animals","author":"Pakes","year":"1985"},{"key":"key\n\t\t\t\t20180504093750_R56-13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF00308718","article-title":"Localization of basic fibroblastic growth factor, a mitogen and angiogenic factor in human brain tumors","volume":"79","author":"Paulus","year":"1990","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180504093750_R57-13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/bjc.1992.272","article-title":"Suramin prevents neovascularization and tumor growth through blocking of basic fibroblastic growth factor activity","volume":"66","author":"Pesenti","year":"1992","journal-title":"Br J Canc"},{"key":"key\n\t\t\t\t20180504093750_R58-13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3171\/jns.1990.73.1.0106","article-title":"Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum free medium","volume":"73","author":"Pollack","year":"1990","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t20180504093750_R59-13","first-page":"3182","article-title":"Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line","volume":"52","author":"Pommier","year":"1992","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R60-13","first-page":"452","article-title":"Protection of the sleeping sickness trypanosome from chemotherapy by different parts of the brain","volume":"62","author":"Raseroka","year":"1985","journal-title":"E Afr Med J"},{"key":"key\n\t\t\t\t20180504093750_R61-13","first-page":"64","article-title":"Use of adaptive control with feedback to individualize suramin dosing","volume":"52","author":"Scher","year":"1992","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R62-13","first-page":"4694","article-title":"Antiproliferative effects of suramin on lymphoid cells","volume":"47","author":"Spigelman","year":"1987","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R63-13","first-page":"5760","article-title":"Acidic and basic fibroblastic growth factor are in glioblastoma multiforme","volume":"51","author":"Stefanik","year":"1991","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180504093750_R64-13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1200\/JCO.1989.7.4.499","article-title":"Suramin: An anticancer drug with a unique mechanism of action","volume":"7","author":"Stein","year":"1989","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180504093750_R65-13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.2565047","article-title":"Allelotypes of colorectal carcinomas","volume":"24","author":"Vogelstein","year":"1989","journal-title":"Science"},{"key":"key\n\t\t\t\t20180504093750_R66-13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00165528","article-title":"Receptors for platelet derived growth factor in human glioma cell lines and influence of suramin on cell proliferation","volume":"11","author":"Westphal","year":"1991","journal-title":"J Neurooncol"},{"key":"key\n\t\t\t\t20180504093750_R67-13","first-page":"5287","article-title":"Platelet-derived growth factor receptors form a high affinity state in membrane preparations","volume":"259","author":"Williams","year":"1984","journal-title":"Kinetics and affinity cross-linking studies. J Biol Chem"},{"key":"key\n\t\t\t\t20180504093750_R68-13","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1073\/pnas.84.19.6899","article-title":"Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification","volume":"84","author":"Wong","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180504093750_R69-13","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1128\/MCB.8.4.1816","article-title":"Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erb B) in human brain tumors","volume":"8","author":"Yamazaki","year":"1988","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20180504093750_R70-13","first-page":"7393","article-title":"Immunohistochemical localization of basic fibroblastic growth factor in astrocytomas","volume":"50","author":"Zagzag","year":"1990","journal-title":"Cancer Res"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/34\/2\/297\/24602996\/0006123-199402000-00013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T17:28:18Z","timestamp":1668101298000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.lww.com\/00006123-199402000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,2,1]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,2,1]]}},"URL":"https:\/\/doi.org\/10.1227\/00006123-199402000-00013","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1994,2]]},"published":{"date-parts":[[1994,2,1]]}}}